Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up
Crossref DOI link: https://doi.org/10.1007/s00198-016-3789-y
Published Online: 2016-10-20
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Belhassen, M.
Confavreux, C. B.
Cortet, B.
Lamezec, L.
Ginoux, M.
Van Ganse, E.
Funding for this research was provided by:
MSD France
License valid from 2016-10-20